Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?

por Elzagheid, A, Kuopio, T, Pyrhönen, S, Collan, Y
Publicado 2006

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer.

por Pyrhönen, S., Kuitunen, T., Nyandoto, P., Kouri, M.
Publicado 1995

Electrical machine drives control: an introduction

por Pyrhonen , Juha, Hrabovcova , Valeria, Semken, R Scott
Publicado 2016

Prognostic factors in prostate cancer

por Buhmeida, A, Pyrhönen, S, Laato, M, Collan, Y
Publicado 2006

DNA aneuploidy and low S-phase fraction as favourable prognostic signs in metastatic melanoma.

por Muhonen, T., Pyrhönen, S., Laasonen, A., Asko-Seljavaara, S., Franssila, K.
Publicado 1991

Familial Breast Cancer in Southern Finland

por Eerola, Hannaleena, Blomqvist, Carl, Pyrhönen, Seppo, Nevanlinna, Heli
Publicado 1999

The effect of vascular endothelial growth factor-1 expression on survival of advanced colorectal cancer patients

por Bendardaf, Riyad, El-Serafi, Ahmed, Syrjänen, Kari, Collan, Yrjö, Pyrhönen, Seppo
Publicado 2017

Diagnosis delay in Libyan female breast cancer

por Ermiah, Eramah, Abdalla, Fathi, Buhmeida, Abdelbaset, Larbesh, Entesar, Pyrhönen, Seppo, Collan, Yrjö
Publicado 2012

The prognostic value of DNA-ploidy in colorectal carcinoma: a prospective study.

por Kouri, M., Pyrhönen, S., Mecklin, J. P., Järvinen, H., Laasonen, A., Franssila, K., Nordling, S.
Publicado 1990

Tumour growth rate and DNA flow cytometry parameters as prognostic factors in metastatic melanoma.

por Muhonen, T., Pyrhönen, S., Laasonen, A., Wasenius, V. M., Asko-Seljavaara, S., Franssila, K., Kangas, L.
Publicado 1992

Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women

por Marttunen, M B, Cacciatore, B, Hietanen, P, Pyrhönen, S, Tiitinen, A, Wahlström, T, Ylikorkala, O
Publicado 2001

Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer

por Korkeila, E. A., Salminen, T., Kallio, R., Mikkola, M., Auvinen, P., Pyrhönen, S., Ristamäki, R.
Publicado 2017

Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer

por Korkeila, E, Talvinen, K, Jaakkola, P M, Minn, H, Syrjänen, K, Sundström, J, Pyrhönen, S
Publicado 2009

Reply: expression of carbonic anhydrase IX suggests poor response to therapy in rectal cancer

por Korkeila, E, Talvinen, K, Jaakkola, P M, Minn, H, Syrjänen, K, Sundström, J, Pyrhönen, S
Publicado 2009

Prognostic Value of Proliferation Markers: Immunohistochemical Ki-67 Expression and Cytometric S-Phase Fraction of Women with Breast Cancer in Libya

por Ermiah, Eramah, Buhmeida, Abdelbaset, Abdalla, Fathi, Khaled, Ben Romdhane, Salem, Nada, Pyrhönen, Seppo, Collan, Yrjö
Publicado 2012

Melanoma-Associated Cancer-Testis Antigen 16 (CT16) Regulates the Expression of Apoptotic and Antiapoptotic Genes and Promotes Cell Survival

por Nylund, Camilla, Rappu, Pekka, Pakula, Eveliina, Heino, Aleksi, Laato, Laura, Elo, Laura L., Vihinen, Pia, Pyrhönen, Seppo, Owen, Gethin R., Larjava, Hannu, Kallajoki, Markku, Heino, Jyrki
Publicado 2012

Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial

por Joensuu, H., Sailas, L., Alanko, T., Sunela, K., Huuhtanen, R., Utriainen, M., Kokko, R., Bono, P., Wigren, T., Pyrhönen, S., Turpeenniemi-Hujanen, T., Asola, R., Leinonen, M., Hahka-Kemppinen, M., Kellokumpu-Lehtinen, P.
Publicado 2010